A Phase II Study of Venetoclax and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)
The goal of this clinical research study is to learn if venetoclax given in combination with ibrutinib can help to control CLL or SLL. The safety of the drug combination will be also studied.
Treatment Location: N/A
IRB Review and Approval Date: 07/07/2016
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: